跳至主要内容
临床试验/CTRI/2013/12/004233
CTRI/2013/12/004233进行中(未招募)未知

TO CORELATE REDUCTION IN PANCREATIC PARENCHYMA FOLLOWING PANCREATICODUODENECTOMY WITH RISK OF NEW-ONSET DIABETES USING MULTIDETECTOR ROW COMPUTED TOMOGRAPHY IMAGING VOLUMETRY - PPDDM

AIIMS0 个研究点目标入组 84 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
AIIMS
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients with resectable periampullary carcinoma who give informed consent for the study

排除标准

  • Patients with diabetes mellitus
  • Patients with pancreatic carcinoma
  • Patients with periampullary carcinoma with associated pancreatic edema, unclear border or evidence of chronic pancreatitis
  • ASA grade III / IV
  • ECOG III / IV
  • Patients who decline to consent

研究者

发起方
AIIMS

相似试验

招募中
不适用
Prospective study for the effects of pancreatic enzyme replacement therapy on quality of life and nutritional assessment after pancreas resectioDiseases of the digestive system
KCT0000010Seoul National University232
进行中(未招募)
1 期
Randomized phase II trial with propranolol and etodolac for patients with tumor resection of the pancreatic head.Patients with pancreatic carcinoma treated by pancreatoduodenectomy.MedDRA version: 21.0Level: LLTClassification code 10033659Term: PancreatoduodenectomySystem Organ Class: 100000004865
EUCTR2018-000415-25-DEniversity Hospital Heidelberg80
招募中
不适用
Prospectivestudy on the treatment effect of pancrelipase on chronic pancreatitis patient's alubumin concentratioChronic pancreatitis
JPRN-UMIN000009547Department of Internal Medicine Second Teaching Hospital Fujita Health University School of Medicine83
已完成
不适用
Association of pancreatic PArenchymal RISk factors with postoperative pancreatic fistula after partial pancreaticoduodenectomy - PARIS studyScheduled elective partial pancreaticoduodenectomy
DRKS00017184niversitätsklinikum Heidelberg270
进行中(未招募)
不适用
A STUDY TO INVESTIGATE THE EFFECT OF PANCRELIPASE DELAYED RELEASE CAPSULES ON MALDIGESTION IN PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CHRONIC PANCREATITIS AND PANCREATECTOMYPancreatic enzyme replacement therapy is the cornerstone of nutritional management of pancreatic exocrine insufficiency (PEI) due to e.g. cystic fibrosis, chronic pancreatitis, partial or complete pancreatectomy or gastrectomy. Without pancreatic enzyme replacement the patients suffer from severe symptoms of maldigestion as manifested by steatorrhea, abdominal pain, body weight loss etc.MedDRA version: 9.1Level: LLTClassification code 10009093Term: Chronic pancreatitisMedDRA version: 9.1Level: LLTClassification code 10033596Term: Pancreatectomy
EUCTR2007-004004-12-BGSolvay Pharmaceuticals GmbH52